US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
オーストラリア
ASX
Inoviq Ltd (IIQO) 銘柄情報

Inoviq Ltd (IIQO)

0.001

0.00

( 0.00% )

更新日時： 09:00:00

Inoviq Ltd (IIQO) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

0.001

( - )

買値

0.001

売値

0.001

出来高

0.00

0.00 日の範囲 0.00

0.001 52 週間の範囲 0.135

時価総額

前日終値

0.001

始値

-

時刻

最終取引時間

-

財務取引量

-

VWAP

-

平均取引量 (3 か月)

AUD 92,318

発行済株式数

140,775,458

配当利回り

PER

-5.52

1 株当たり利益 (EPS)

-0.06

歳入

2.1M

純利益

-7.24M

INOVIQ Ltd develops and commercializes diagnostic and exosome-based products to enhance the diagnosis and treatment of cancer and other diseases in Australia and the United States. It offers hTERT ICC test, an immunocytochemistry test used as an adjunct to urine cytology testing for bladder cancer; ... INOVIQ Ltd develops and commercializes diagnostic and exosome-based products to enhance the diagnosis and treatment of cancer and other diseases in Australia and the United States. It offers hTERT ICC test, an immunocytochemistry test used as an adjunct to urine cytology testing for bladder cancer; and EXO-NET, an EV isolation tool for biomarker discovery and diagnostic development. It offers non-invasive, diagnostics using its proprietary exosome develops technologies for improved screening, diagnosis, treatment selection and monitoring of cancer and other diseases. The company was formerly known as BARD1 Life Sciences Limited and changed its name to INOVIQ Ltd in December 2021. INOVIQ Ltd was founded in 2016 and is headquartered in Notting Hill, Australia. 詳細を表示

セクター

Healthcare

業界

Medical Diagnostics & Screening

ウェブサイト

www.inoviq.com

本社

Notting Hill, Australia

設立

2026

Inoviq Ltd is listed in the Healthcare sector of the オーストラリア証券取引所 with ticker IIQO. The last closing price for Inoviq was AUD0. Over the last year, Inoviq shares have traded in a share price range of AUD 0.001 to AUD 0.135.

Inoviq currently has 140,775,458 shares in issue. The market capitalisation of Inoviq is AUD140,775.46 . Inoviq has a price to earnings ratio (PE ratio) of -5.52.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0.001	0.001	0.001	23250	0.001	DE
26	-0.009	-90	0.01	0.01	0.001	11545	0.001	DE
52	-0.119	-99.1666666667	0.12	0.135	0.001	9003	0.02722136	DE
156	-0.001	-50	0.002	0.16	0.001	22308	0.09173296	DE
260	-0.199	-99.5	0.2	0.21	0.001	20524	0.08311974	DE

IIQO - Frequently Asked Questions (FAQ)

What is the current Inoviq Ltd share price?

The current share price of Inoviq Ltd is AUD 0.001

How many Inoviq Ltd shares are in issue?

Inoviq Ltd has 140,775,458 shares in issue

What is the market cap of Inoviq Ltd?

The market capitalisation of Inoviq Ltd is AUD 140.78k

What is the 1 year trading range for Inoviq Ltd share price?

Inoviq Ltd has traded in the range of AUD 0.001 to AUD 0.135 during the past year

What is the PE ratio of Inoviq Ltd?

The price to earnings ratio of Inoviq Ltd is -5.52

What is the cash to sales ratio of Inoviq Ltd?

The cash to sales ratio of Inoviq Ltd is 22.77

What is the registered address of Inoviq Ltd?

The registered address for Inoviq Ltd is 23 Normanby Road, Notting Hill, Victoria, 3168

What is the Inoviq Ltd website address?

The website address for Inoviq Ltd is www.inoviq.com

Which industry sector does Inoviq Ltd operate in?

Inoviq Ltd operates in the Medical Diagnostics & Screening sector

surfer44

surfer44 3分前

10th Capital Link Maritime Leaders Summit – Greece | Tanker Markets in Motion

https://youtu.be/cQmTuuAZef8

wildwertski

wildwertski 4分前

Not to be a negative Nelly, but this is what happens when you have an app in beta for a whole year and wait for 3 weeks before the big day to start making serious updates. I sure hope someone can pull a rabbit out from behind that preverbal curtain soon. Getting "blown away" isn't working for us.

Stockman1010101

Stockman1010101 6分前

All the IPO underwriters are making a fortune running these MEGA IPOs. I suspect all the big name underwriters will be stinky rich when Fannie & Freddie have their long awaited IPO.
HOLD THEM.SHARES THEY WILL BE WORTH NORTH OF $100/SHARE SOON.
GLTA

rjs1

Rainmaker 2026 Valuation Model

Three Layer Architecture:
• Asset Light Corporate Layer (RAKR HQ – Canada)
• Operating Layer (Miranda Water Technologies)
• Market Nodes (U.S., Canada, Mexico)
Each layer has its own valuation logic, revenue cadence, and ri

JusticeWillWin

JusticeWillWin 11分前

Again ~3.5M at the close...

Sleepy$$$

Sleepy$$$ 25分前

Outstanding Shares642,268,09705/29/2026Restricted625,012,64605/29/2026

Per otcmarkets.... float is tiny

Duke Knockem

Duke Knockem 27分前

I asked Belisarian holdings if they would take over Gs tickers, they didn't respond, but they 'liked' my post on Twitter. In 4 years it was only the second time they liked one of my post....🤷....to take with a grain of salt

nowwhat2

nowwhat2 31分前

STOP

https://www.youtube.com/watch?v=JNhayv6hBeo
https://investorshub.advfn.com/uimage/uploads/2026/6/12/netmygold_june_11_3m_daily_w_asian_guy.jpg

https://investorshub.advfn.com/uimage/uploads/2026/6/12/udfnigold_june_11_3y_w_asian_guy.jpg

https:/

nowwhat2

nowwhat2 32分前

STOP

https://www.youtube.com/watch?v=JNhayv6hBeo
https://investorshub.advfn.com/uimage/uploads/2026/6/12/netmygold_june_11_3m_daily_w_asian_guy.jpg

https://investorshub.advfn.com/uimage/uploads/2026/6/12/udfnigold_june_11_3y_w_asian_guy.jpg

https:/

axelvento

axelvento 32分前

Ovarian cancer CAR-T therapy, lira-cel, presentation to highlight positive survival observations from ongoing Phase 1 clinical trial

Breast cancer vaccine presentation to include final Phase 1 data showing all major primary endpoints were met and protocol-defined immune responses in 7

JohnnyRotton

JohnnyRotton 40分前

Wasn't to get sellers cause no one bought my sell order, cant get out now. Stuck. Just a small order.

jimr1717

jimr1717 41分前

I seriously doubt Nelson or Hawkins care who their marks are that they dump their shares on

ElectricDwarf15

ElectricDwarf15 44分前

Stuck short INHD after the T12 halt and looking to connect with anyone holding long shares who wants to exit.

I'm with Cobra DM me if interested.

knrorrel

knrorrel 45分前

$PAVD - It kicks off today. You might think—after the stock was bought up at a really nice, low price yesterday—that we’re going to skyrocket today, and all the people who didn't have the guts to buy yesterday and have been waiting on the sidelines will jump in; the stock could become a multi-dolla

ap17

Word on the street, the village Idiot, aka sims is going to change the traffic pattern. LMFAO
Don't forget! This about YOU! OUCH!!!
Might want to change that traffic pattern....so you can sit! LMFAO!!

https://www.instagram.com/p/DSS1QQ4EZk9/

Elon Musk: congratulations! Our country is lucky to have you…and you have excelled through hard work to help create the modern world more than anyone since Steve Jobs. You also are a father of many kids and are active in their lives. You have a great sense of humor and wit, and never before in histo

ace65

Up 100% ...excellent day with massive volume.
No complaints here.
Bought a chunk at .0004 and added .0005s.
Looking like .00s are coming.

knrorrel

knrorrel 50分前

It kicks off today. You might think—after the stock was bought up at a really nice, low price yesterday—that we’re going to skyrocket today, and all the people who didn't have the guts to buy yesterday and have been waiting on the sidelines will jump in; the stock could become a multi-dollar runner—

jour_trader

jour_trader 51分前

Valid question. Elite was up against a billion dollar organization known for dragging out patent protections time and time again. I think Elite and Accord’s cases brought to light the craziness of what Purdue was doing and perhaps the cases prevented further attempts at extending patents that the co

knrorrel

knrorrel 53分前

GM - watch $PAVS today, bid / ask moving higher 🚀

ddls

You know the stock is in trouble when even ddls's posts start thinning out.

Everyone's waiting for financials next year to see if any progress is being made here. Until then we should call BioElectronics Boring BIEL.

jour_trader

jour_trader 56分前

Yes, precisely. Now they can include with more certainty the financial value of Oxy in the DCF.

jour_trader

jour_trader 57分前

Nasrat will likely now be able to provide more clarification with case officially ending. Been a long road with a decent outcome. Eager to watch Accord to see what takes place with them and if they have first to file rights.

mrwrn2010

mrwrn2010 58分前

Saw that too. Possible M&A clause? 👀🧐🤔

ace65

WOW...just saw the eod Level II .WTF happened.
A high of .0037 million bought.

Pet Center Comercio E Pa... ON

Tempus Resources

Danieli & C - Officine M...

Aldoro Resources

WisdomTree Japan Equity ...

Synthetic Fixed Income S...

Pacific Bauxite

Radiopharm Theranostics

Deferred Settlement Trad...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。